Export 550 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
Journal Article
Z. - Di Xia, Ma, R. - X., Wen, J. - F., Zhai, Y. - F., Wang, Y. - Q., Wang, F. - Y., Liu, D., Zhao, X. - L., Sun, B., Jia, P., and Zheng, X. - H., Pathogenesis, Animal Models, and Drug Discovery of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. 4, pp. 1265-1301, 2023.
M. Jucker and Walker, L. C., Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders., Ann Neurol, vol. 70, no. 4, pp. 532-40, 2011.
N. Voyle, Keohane, A., Newhouse, S., Lunnon, K., Johnston, C., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Hodges, A., Kiddle, S., and Dobson, R. Jb, A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis., J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
N. Y. Kirson, J Andrews, S., Desai, U., King, S. B., Schonfeld, S., Birnbaum, H. G., Ball, D. E., and Kahle-Wrobleski, K., Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 295-307, 2018.
G. Fernández, Manes, F., Politi, L. E., Orozco, D., Schumacher, M., Castro, L., Agamennoni, O., and Rotstein, N. P., Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique., J Alzheimers Dis, vol. 50, no. 3, pp. 827-38, 2016.
Y. Moon, Han, S. - H., and Moon, W. - J., Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging., J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
A. Pistono, Jucla, M., Barbeau, E. J., Saint-Aubert, L., Lemesle, B., Calvet, B., Köpke, B., Puel, M., and Pariente, J., Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 687-98, 2016.
L. Wang, Chen, H., Tang, J., Guo, Z., and Wang, Y., Peptidylarginine Deiminase and Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.
P. Suppa, Hampel, H., Kepp, T., Lange, C., Spies, L., Fiebach, J. B., Dubois, B., and Buchert, R., Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 51, no. 3, pp. 867-73, 2016.
R. Milne, Bunnik, E., Diaz, A., Richard, E., Badger, S., Gove, D., Georges, J., Fauria, K., Molinuevo, J. - L., Wells, K., Ritchie, C., and Brayne, C., Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals., J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
M. Ettcheto, Busquets, O., Cano, A., Sánchez-López, E., Manzine, P. R., Espinosa-Jimenez, T., Verdaguer, E., Sureda, F. X., Olloquequi, J., Castro-Torres, R. D., Auladell, C., Folch, J., Casadesus, G., and Camins, A., Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S91-S107, 2021.
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
R. Olmos-Villaseñor, Sepulveda-Silva, C., Julio-Ramos, T., Fuentes-Lopez, E., Toloza-Ramirez, D., Santibañez, R. A., Copland, D. A., and Mendez-Orellana, C., Phonological and Semantic Fluency in Alzheimer's Disease: A Systematic Review and Meta-Analysis., J Alzheimers Dis, vol. 95, no. 1, pp. 1-12, 2023.
M. Rafi Khezri, Ghasemnejad-Berenji, M., and Moloodsouri, D., The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?, J Alzheimers Dis, vol. 92, no. 2, pp. 391-393, 2023.
K. Deniz, Ho, C. C. G., Malphrus, K. G., Reddy, J. S., Nguyen, T., Carnwath, T. P., Crook, J. E., Lucas, J. A., Graff-Radford, N. R., Carrasquillo, M. M., and Ertekin-Taner, N., Plasma Biomarkers of Alzheimer's Disease in African Americans., J Alzheimers Dis, vol. 79, no. 1, pp. 323-334, 2021.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
P. Chatterjee, Lim, W. L. F., Shui, G., Gupta, V. B., James, I., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., Benzinger, T., Masters, C., Snowden, S. G., Wenk, M. R., Bateman, R. J., Morris, J. C., and Martins, R. N., Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study., J Alzheimers Dis, vol. 50, no. 3, pp. 887-94, 2016.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., Plasma phospholipids identify antecedent memory impairment in older adults., Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
Y. Jayne Tan, Siow, I., Saffari, S. Ehsan, Ting, S. K. S., Li, Z., Kandiah, N., Tan, L. C. S., Tan, E. King, and Ng, A. S. L., Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition., J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
B. McGuinness, Fuchs, M., Barrett, S. L., A Passmore, P., and Johnston, J. A., Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study., J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
C. S. Atwood and Perry, G., Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
J. Lakey-Beitia, Burillo, A. M., La Penna, G., Hegde, M. L., and Rao, K. S., Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S335-S357, 2021.
P. L. Nara, Sindelar, D., Penn, M. S., Potempa, J., and W Griffin, S. T., Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. 4, pp. 1417-1450, 2021.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials., J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
R. Smith, Wibom, M., Olsson, T., Hägerström, D., Jögi, J., Rabinovici, G. D., and Hansson, O., Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation., J Alzheimers Dis, vol. 51, no. 2, pp. 339-43, 2016.